Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
Clinical trial NCT04243551 · TERMINATED
Trial details
- NCT number
- NCT04243551
- Sponsor
- Entero Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2023-10-16
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.